Pineapple Express Cannabis Company (PNXP) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
9 Jun, 2025Executive summary
Fiscal year ended January 31, 2025, marked by a strategic pivot from direct cannabis retail to blockchain-based technology for the cannabis sector, highlighted by the divestiture of Pineapple Consolidated Inc. and acquisition of GROOVY Company, Inc.
Company recorded minimal revenues, continued net losses, and faces substantial doubt about its ability to continue as a going concern.
Leadership transition occurred in February 2025, with Franjose Yglesias appointed CEO following the resignation of Matthew Feinstein.
Financial highlights
Revenue for the year ended January 31, 2025 was $16,168, with most deemed uncollectible, resulting in a $14,204 bad debt expense.
Net loss for the year was $31,153, an improvement from the prior year's net loss of $59,497.
Cash balance at year-end was $0, with a working capital deficit of $2,079 and accumulated deficit of $673,646.
No dividends were paid; 19,834,550 shares of common stock were outstanding as of January 31, 2025.
Outlook and guidance
Management plans to commercialize blockchain authentication technology in cannabis supply chains and pursue additional financing.
Substantial doubt remains about the company's ability to continue as a going concern without new capital or improved operations.
Latest events from Pineapple Express Cannabis Company
- No revenue, large net loss, all debt in default, and substantial going concern risk.PNXP
Q3 202619 Dec 2025 - Net income turned to a loss in Q1 2024 as expansion continued and funding risks persisted.PNXP
Q1 202415 Oct 2025 - No revenue, large net loss, all notes in default, and major going concern risk after GROOVY acquisition.PNXP
Q2 20269 Sep 2025 - Significant quarterly loss, no revenue, defaulted debt, and major blockchain acquisition highlight ongoing risks.PNXP
Q1 202523 Jun 2025 - Quarterly revenue and net income improved, but liquidity remains a critical concern.PNXP
Q2 202413 Jun 2025 - No revenue, rising losses, and going concern risk highlight Pineapple Express's FY2024 challenges.PNXP
Q4 202413 Jun 2025 - No revenue, rising losses, and going concern doubts highlight major risks for Pineapple Express Cannabis Company.PNXP
Q4 202313 Jun 2025 - Quarterly revenue growth and narrowed loss highlight expansion, but going concern risk remains.PNXP
Q3 20255 Jun 2025